Health professionals are encouraged to take the ESC Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

In 2019, the Japanese Circulation Society published 2 guidelines in the field of coronary
artery disease (CAD):(1) a guideline for acute coronary syndrome (ACS) that integrated …

Importance The effect of ticagrelor with or without aspirin on saphenous vein graft patency in
patients undergoing coronary artery bypass grafting (CABG) is unknown. Objective To …

Importance The role of ticagrelor with or without aspirin after coronary artery bypass graft
surgery remains unclear. Objective To compare the risks of vein graft failure and bleeding …

Objective To assess the effects of different oral antithrombotic drugs that prevent saphenous
vein graft failure in patients undergoing coronary artery bypass graft surgery. Design …

BACKGROUND: Approximately 15% of saphenous vein grafts (SVGs) occlude during the
first year after coronary artery bypass graft surgery (CABG) despite aspirin use. The POPular …

Objective To assess the effect of different antiplatelet strategies on clinical outcomes after
coronary artery bypass grafting. Design Five year follow-up of randomised Different …

Antiplatelet therapy plays a crucial role in a number of cardiovascular disorders. We
currently have a range of antiplatelet agents in our armamentarium. In this review, we aim to …

Coronary artery bypass grafting is the most commonly performed cardiac surgical
procedure. Conduit selection is crucial to achieving early optimal outcomes, with graft …

Background Antiplatelet therapy prevents saphenous vein graft (SVG) occlusion and
improves outcomes after coronary artery bypass graft surgery (CABG). However, the optimal …